Conditions placed on Ranbaxy acquisition


Sun Pharmaceuticals Industries can complete its $4 billion purchase of Ranbaxy Laboratories if it sells Ranbaxy’s interests in generic minocycline tablets to Torrent Pharmaceuticals Ltd., according to the Federal Trade Commission. The FTC gave final approval to a settlement with the drug companies that would preserve competition for minocycline tablets,